Home > Insider Trading > Filing (0001209191-18-013198)

Filing Details

Accession Number:: 0001209191-18-013198
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-02-23 21:58:36
Reporting Period:: 2018-02-22

Accepted Time:: 2018-02-23 21:58:36
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
921299	Fibrogen Inc	FGEN	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1623238	B Thomas Neff	C/O Fibrogen, Inc. 409 Illinois St. San Francisco CA 94158	Chief Executive Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2018-02-22	10,265	$2.35	2,955,614	No	4	M	Direct
Common Stock	Disposition	2018-02-22	8,749	$56.50	2,946,865	No	4	S	Direct
Common Stock	Disposition	2018-02-22	10,051	$57.43	2,936,814	No	4	S	Direct
Common Stock	Disposition	2018-02-22	100	$58.03	2,936,714	No	4	S	Direct
Common Stock	Disposition	2018-02-22	618	$56.50	123,552	No	4	S	Indirect	By Family Partnership
Common Stock	Disposition	2018-02-22	300	$57.72	123,252	No	4	S	Indirect	By Family Partnership
Common Stock	Acquisiton	2018-02-23	10,265	$2.35	2,946,979	No	4	M	Direct
Common Stock	Disposition	2018-02-23	11,400	$55.90	2,935,579	No	4	S	Direct
Common Stock	Disposition	2018-02-23	6,500	$56.89	2,929,079	No	4	S	Direct
Common Stock	Disposition	2018-02-23	1,000	$57.40	2,928,079	No	4	S	Direct
Common Stock	Disposition	2018-02-23	500	$55.79	122,752	No	4	S	Indirect	By Family Partnership
Common Stock	Disposition	2018-02-23	418	$57.11	122,334	No	4	S	Indirect	By Family Partnership

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Indirect	By Family Partnership
No	4	S	Indirect	By Family Partnership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Indirect	By Family Partnership
No	4	S	Indirect	By Family Partnership

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2018-02-22	10,265	$0.00	10,265	$2.35
Common Stock	Stock Option (Right to Buy)	Disposition	2018-02-23	10,265	$0.00	10,265	$2.35

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
27,535		2018-03-12	No	4	M	Direct
17,270		2018-03-12	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	19,500	Indirect	By spouse
Common Stock	60,946	Indirect	See footnote

Footnotes

Shares sold pursuant to a 10b5-1 plan.
The shares were sold at prices ranging from $56.00 to $56.975. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The shares were sold at prices ranging from $57.00 to $57.925. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The shares were sold at prices ranging from $56.125 to $57.05. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The shares were sold at prices ranging from $57.60 to $57.80. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The shares were sold at prices ranging from $55.35 to $56.30. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The shares were sold at prices ranging from $56.35 to $57.30. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The shares were sold at prices ranging from $57.35 to $57.50. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The shares were sold at prices ranging from $55.45 to $56.20. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The shares were sold at prices ranging from $56.725 to $57.40. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The shares are held by BioGrowth Partners, LP. The reporting person is the sole general partner of BioGrowth Partners, LP and has sole voting and dispositive power over the shares held by BioGrowth Partners, LP.
Fully vested.